Education
About Us
Working with TipRanks
Follow Us
Medexus Pharmaceuticals (TSE:MDP)
:MDP
RESEARCH TOOLSreports
| Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 108.33M | $ 113.05M | $ 108.10M | $ 76.70M | $ 79.66M |
| Gross Profit | $ 56.58M | $ 59.51M | $ 60.04M | $ 37.93M | $ 42.01M |
| Operating Income | $ 8.22M | $ 10.79M | $ 7.61M | $ -15.00M | $ -1.38M |
| EBITDA | $ 16.81M | $ 19.28M | $ 16.14M | $ 15.16M | $ -23.61M |
| Net Income | $ 2.25M | $ -214.00K | $ 1.22M | $ -2.88M | $ -28.26M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 23.97M | $ 5.25M | $ 13.07M | $ 10.02M | $ 18.70M |
| Total Assets | $ 171.84M | $ 155.73M | $ 161.33M | $ 139.22M | $ 148.51M |
| Total Debt | $ 37.18M | $ 49.90M | $ 94.72M | $ 54.86M | $ 56.40M |
| Net Debt | $ 13.21M | $ 44.64M | $ 77.06M | $ 56.06M | $ 32.89M |
| Total Liabilities | $ 119.69M | $ 125.41M | $ 187.70M | $ 151.82M | $ 130.50M |
| Stockholders' Equity | $ 52.14M | $ 30.32M | $ 22.45M | $ 17.79M | $ 18.02M |
| Cash Flow | |||||
| Free Cash Flow | $ 21.31M | $ 18.45M | $ -1.81M | $ -8.89M | $ -5.72M |
| Operating Cash Flow | $ 24.03M | $ 18.71M | $ -1.44M | $ -1.18M | $ 5.04M |
| Investing Cash Flow | $ -6.00M | $ -3.48M | $ -1.72M | $ -8.20M | $ -11.70M |
| Financing Cash Flow | $ 796.00K | $ -23.05M | $ 6.41M | $ 663.00K | $ 18.68M |